 | • レポートコード：MRC23Q36497 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の美容注射剤市場について調査・分析し、世界の美容注射剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（頬/こめかみにあるくぼみ、小鼻/口元ほうれい線（マリオネットライン・ほうれい線）改善、唇のボリュームアップ、顔輪郭改善）、用途別セグメント分析（病院、美容クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Allergan Plc、Galderma SA、Merz Pharma GmbH & Co KgaA、Sinclair Pharma Plc、Teoxane SA、Bohus BioTech AB、AbbVie Inc、Huadong Medicine Co., Ltdなどが含まれています。 世界の美容注射剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、美容注射剤市場規模を推定する際に考慮しました。本レポートは、美容注射剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、美容注射剤に関するビジネス上の意思決定に役立てることを目的としています。 ・美容注射剤市場の概要 - 製品の定義 - 美容注射剤のタイプ別セグメント - 世界の美容注射剤市場規模：タイプ別分析（頬/こめかみにあるくぼみ、小鼻/口元ほうれい線（マリオネットライン・ほうれい線）改善、唇のボリュームアップ、顔輪郭改善） - 美容注射剤の用途別セグメント - 世界の美容注射剤市場規模：用途別分析（病院、美容クリニック） - 世界の美容注射剤市場規模予測（2018年-2029年） - 美容注射剤の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 美容注射剤市場の競争状況およびトレンド ・美容注射剤の地域別市場規模 - 北米の美容注射剤市場規模（2018年-2029年） - アメリカの美容注射剤市場規模（2018年-2029年） - ヨーロッパの美容注射剤市場規模（2018年-2029年） - アジア太平洋の美容注射剤市場規模（2018年-2029年） - 中国の美容注射剤市場規模（2018年-2029年） - 日本の美容注射剤市場規模（2018年-2029年） - 韓国の美容注射剤市場規模（2018年-2029年） - インドの美容注射剤市場規模（2018年-2029年） - オーストラリアの美容注射剤市場規模（2018年-2029年） - 中南米の美容注射剤市場規模（2018年-2029年） - 中東・アフリカの美容注射剤市場規模（2018年-2029年） ・タイプ別セグメント：頬/こめかみにあるくぼみ、小鼻/口元ほうれい線（マリオネットライン・ほうれい線）改善、唇のボリュームアップ、顔輪郭改善 - 世界の美容注射剤のタイプ別販売量（2018年-2023年） - 世界の美容注射剤のタイプ別売上（2018年-2023年） - 世界の美容注射剤のタイプ別価格 ・用途別セグメント：病院、美容クリニック - 世界の美容注射剤の用途別販売量（2018年-2023年） - 世界の美容注射剤の用途別売上（2018年-2023年） - 世界の美容注射剤の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Allergan Plc、Galderma SA、Merz Pharma GmbH & Co KgaA、Sinclair Pharma Plc、Teoxane SA、Bohus BioTech AB、AbbVie Inc、Huadong Medicine Co., Ltd ・産業チェーンと販売チャネルの分析 - 美容注射剤産業チェーン分析 - 美容注射剤の主要原材料 - 美容注射剤の販売チャネル - 美容注射剤のディストリビューター - 美容注射剤の主要顧客 ・美容注射剤市場ダイナミクス - 美容注射剤の業界動向 - 美容注射剤市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance
Highlights
The global Aesthetic Injectables market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Aesthetic Injectables is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Aesthetic Injectables is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Aesthetic Injectables include Allergan Plc, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Plc, Teoxane SA, Bohus BioTech AB, AbbVie Inc and Huadong Medicine Co., Ltd, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aesthetic Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aesthetic Injectables.
The Aesthetic Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Aesthetic Injectables market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aesthetic Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Allergan Plc
Galderma SA
Merz Pharma GmbH & Co KgaA
Sinclair Pharma Plc
Teoxane SA
Bohus BioTech AB
AbbVie Inc
Huadong Medicine Co., Ltd
Segment by Type
Sunken Cheeks or Temples
Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
Plumping Up Lips
Enhancing Facial Contour
Segment by Application
Hospital
Beauty Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aesthetic Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aesthetic Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Aesthetic Injectables Market Overview
1.1 Product Overview and Scope of Aesthetic Injectables
1.2 Aesthetic Injectables Segment by Type
1.2.1 Global Aesthetic Injectables Market Value Comparison by Type (2023-2029)
1.2.2 Sunken Cheeks or Temples
1.2.3 Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
1.2.4 Plumping Up Lips
1.2.5 Enhancing Facial Contour
1.3 Aesthetic Injectables Segment by Application
1.3.1 Global Aesthetic Injectables Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Beauty Clinic
1.4 Global Aesthetic Injectables Market Size Estimates and Forecasts
1.4.1 Global Aesthetic Injectables Revenue 2018-2029
1.4.2 Global Aesthetic Injectables Sales 2018-2029
1.4.3 Global Aesthetic Injectables Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Aesthetic Injectables Market Competition by Manufacturers
2.1 Global Aesthetic Injectables Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aesthetic Injectables Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aesthetic Injectables Average Price by Manufacturers (2018-2023)
2.4 Global Aesthetic Injectables Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Aesthetic Injectables, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aesthetic Injectables, Product Type & Application
2.7 Aesthetic Injectables Market Competitive Situation and Trends
2.7.1 Aesthetic Injectables Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aesthetic Injectables Players Market Share by Revenue
2.7.3 Global Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aesthetic Injectables Retrospective Market Scenario by Region
3.1 Global Aesthetic Injectables Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aesthetic Injectables Global Aesthetic Injectables Sales by Region: 2018-2029
3.2.1 Global Aesthetic Injectables Sales by Region: 2018-2023
3.2.2 Global Aesthetic Injectables Sales by Region: 2024-2029
3.3 Global Aesthetic Injectables Global Aesthetic Injectables Revenue by Region: 2018-2029
3.3.1 Global Aesthetic Injectables Revenue by Region: 2018-2023
3.3.2 Global Aesthetic Injectables Revenue by Region: 2024-2029
3.4 North America Aesthetic Injectables Market Facts & Figures by Country
3.4.1 North America Aesthetic Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Aesthetic Injectables Sales by Country (2018-2029)
3.4.3 North America Aesthetic Injectables Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aesthetic Injectables Market Facts & Figures by Country
3.5.1 Europe Aesthetic Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Aesthetic Injectables Sales by Country (2018-2029)
3.5.3 Europe Aesthetic Injectables Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aesthetic Injectables Market Facts & Figures by Country
3.6.1 Asia Pacific Aesthetic Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Aesthetic Injectables Sales by Country (2018-2029)
3.6.3 Asia Pacific Aesthetic Injectables Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aesthetic Injectables Market Facts & Figures by Country
3.7.1 Latin America Aesthetic Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Aesthetic Injectables Sales by Country (2018-2029)
3.7.3 Latin America Aesthetic Injectables Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aesthetic Injectables Market Facts & Figures by Country
3.8.1 Middle East and Africa Aesthetic Injectables Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Aesthetic Injectables Sales by Country (2018-2029)
3.8.3 Middle East and Africa Aesthetic Injectables Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aesthetic Injectables Sales by Type (2018-2029)
4.1.1 Global Aesthetic Injectables Sales by Type (2018-2023)
4.1.2 Global Aesthetic Injectables Sales by Type (2024-2029)
4.1.3 Global Aesthetic Injectables Sales Market Share by Type (2018-2029)
4.2 Global Aesthetic Injectables Revenue by Type (2018-2029)
4.2.1 Global Aesthetic Injectables Revenue by Type (2018-2023)
4.2.2 Global Aesthetic Injectables Revenue by Type (2024-2029)
4.2.3 Global Aesthetic Injectables Revenue Market Share by Type (2018-2029)
4.3 Global Aesthetic Injectables Price by Type (2018-2029)
5 Segment by Application
5.1 Global Aesthetic Injectables Sales by Application (2018-2029)
5.1.1 Global Aesthetic Injectables Sales by Application (2018-2023)
5.1.2 Global Aesthetic Injectables Sales by Application (2024-2029)
5.1.3 Global Aesthetic Injectables Sales Market Share by Application (2018-2029)
5.2 Global Aesthetic Injectables Revenue by Application (2018-2029)
5.2.1 Global Aesthetic Injectables Revenue by Application (2018-2023)
5.2.2 Global Aesthetic Injectables Revenue by Application (2024-2029)
5.2.3 Global Aesthetic Injectables Revenue Market Share by Application (2018-2029)
5.3 Global Aesthetic Injectables Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan Plc
6.1.1 Allergan Plc Corporation Information
6.1.2 Allergan Plc Description and Business Overview
6.1.3 Allergan Plc Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Plc Aesthetic Injectables Product Portfolio
6.1.5 Allergan Plc Recent Developments/Updates
6.2 Galderma SA
6.2.1 Galderma SA Corporation Information
6.2.2 Galderma SA Description and Business Overview
6.2.3 Galderma SA Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Galderma SA Aesthetic Injectables Product Portfolio
6.2.5 Galderma SA Recent Developments/Updates
6.3 Merz Pharma GmbH & Co KgaA
6.3.1 Merz Pharma GmbH & Co KgaA Corporation Information
6.3.2 Merz Pharma GmbH & Co KgaA Description and Business Overview
6.3.3 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product Portfolio
6.3.5 Merz Pharma GmbH & Co KgaA Recent Developments/Updates
6.4 Sinclair Pharma Plc
6.4.1 Sinclair Pharma Plc Corporation Information
6.4.2 Sinclair Pharma Plc Description and Business Overview
6.4.3 Sinclair Pharma Plc Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sinclair Pharma Plc Aesthetic Injectables Product Portfolio
6.4.5 Sinclair Pharma Plc Recent Developments/Updates
6.5 Teoxane SA
6.5.1 Teoxane SA Corporation Information
6.5.2 Teoxane SA Description and Business Overview
6.5.3 Teoxane SA Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teoxane SA Aesthetic Injectables Product Portfolio
6.5.5 Teoxane SA Recent Developments/Updates
6.6 Bohus BioTech AB
6.6.1 Bohus BioTech AB Corporation Information
6.6.2 Bohus BioTech AB Description and Business Overview
6.6.3 Bohus BioTech AB Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bohus BioTech AB Aesthetic Injectables Product Portfolio
6.6.5 Bohus BioTech AB Recent Developments/Updates
6.7 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AbbVie Inc Aesthetic Injectables Product Portfolio
6.7.5 AbbVie Inc Recent Developments/Updates
6.8 Huadong Medicine Co., Ltd
6.8.1 Huadong Medicine Co., Ltd Corporation Information
6.8.2 Huadong Medicine Co., Ltd Description and Business Overview
6.8.3 Huadong Medicine Co., Ltd Aesthetic Injectables Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Huadong Medicine Co., Ltd Aesthetic Injectables Product Portfolio
6.8.5 Huadong Medicine Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aesthetic Injectables Industry Chain Analysis
7.2 Aesthetic Injectables Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aesthetic Injectables Production Mode & Process
7.4 Aesthetic Injectables Sales and Marketing
7.4.1 Aesthetic Injectables Sales Channels
7.4.2 Aesthetic Injectables Distributors
7.5 Aesthetic Injectables Customers
8 Aesthetic Injectables Market Dynamics
8.1 Aesthetic Injectables Industry Trends
8.2 Aesthetic Injectables Market Drivers
8.3 Aesthetic Injectables Market Challenges
8.4 Aesthetic Injectables Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer